ANAL CANCER

This early-phase trial is testing a new therapeutic HPV vaccine, given alone or combined with an immunotherapy drug called M7824, in people with cancers linked to HPV. The main goals are to find a safe dose and see if the treatments can stimulate the body's immune system to bette…

This study tested an immunotherapy drug called pembrolizumab in people with many different types of advanced solid tumors that had stopped responding to standard treatments. The main goal was to see if the drug could shrink tumors and to identify biological markers that might pre…

This study is testing whether a community program called Potlako+ can help people with possible cancer symptoms get diagnosed and treated faster. The program involves educating communities about cancer warning signs and providing patient navigators to guide people through the hea…

This study is testing a new combination of three immunotherapy drugs for people with advanced cancers that have not responded well to standard treatments. It focuses on cancers linked to HPV (like cervical, throat, and anal cancers) and certain colon cancers. The main goals are t…

This study is testing whether using a lower radiation dose to healthy lymph nodes can reduce treatment side effects for people with anal cancer. The trial involves 33 patients with locally advanced anal cancer who will receive the reduced radiation along with standard chemotherap…

This is an early-stage study to find a safe dose of a new drug called KFA115, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced cancers that have stopped responding to standard treatments. The main goal is to check for side effects and determ…